Abstract
Asymmetrically disubstituted pyrenebutyrate complex of PtIV was examined as cisplatin prodrugs for its anticancer effects in the dark and upon irradiation against leukemic and colorectal cancer cells. The complex exhibited moderate anticancer activity, which increased two to three-fold after being exposed to UV light (365 nm) for 30 minutes. The study shows that the cytotoxicity of the studied complex is closely linked to its ability to undergo activation either through chemical reduction by biological reductants or through photoinduced processes.
Keywords
activation by reduction
anticancer agents
cytotoxicity
photoactivation
platinum(IV) prodrugs
Funders
Bulgarian National Science Fund
KП-06-H59/9